Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019
Precision medicine is a patient-specific approach that integrates all relevant clinical, genetic
and biological information in order to optimise the therapeutic benefit relative to the …
and biological information in order to optimise the therapeutic benefit relative to the …
Chronic obstructive pulmonary disease exacerbation fundamentals: diagnosis, treatment, prevention and disease impact
In chronic obstructive pulmonary disease (COPD), exacerbations (ECOPD), characterized
by an acute deterioration in respiratory symptoms, are fundamental events impacting …
by an acute deterioration in respiratory symptoms, are fundamental events impacting …
Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published the
complete 2023 GOLD report, which can be freely downloaded from its web page (www …
complete 2023 GOLD report, which can be freely downloaded from its web page (www …
Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD
KF Rabe, FJ Martinez, GT Ferguson… - … England Journal of …, 2020 - Mass Medical Soc
Background Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting
muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA) for chronic obstructive …
muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA) for chronic obstructive …
[Translated article] Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD
M Miravitlles, M Calle, J Molina, P Almagro… - Archivos de …, 2022 - Elsevier
Abstract The Spanish COPD Guidelines (GesEPOC) were first published in 2012, and since
then have undergone a series of updates incorporating new evidence on the diagnosis and …
then have undergone a series of updates incorporating new evidence on the diagnosis and …
Update on clinical aspects of chronic obstructive pulmonary disease
BR Celli, JA Wedzicha - New England Journal of Medicine, 2019 - Mass Medical Soc
Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline
Background: This document provides clinical recommendations for the pharmacologic
treatment of chronic obstructive pulmonary disease (COPD). It represents a collaborative …
treatment of chronic obstructive pulmonary disease (COPD). It represents a collaborative …
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary …
GT Ferguson, KF Rabe, FJ Martinez… - The Lancet …, 2018 - thelancet.com
Background Inhaled corticosteroids have been used in patients with chronic obstructive
pulmonary disease (COPD), but the potential benefits of their use in triple therapy are not …
pulmonary disease (COPD), but the potential benefits of their use in triple therapy are not …
Cardiovascular disease and COPD: dangerous liaisons?
Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD)
frequently occur together and their coexistence is associated with worse outcomes than …
frequently occur together and their coexistence is associated with worse outcomes than …
Inflammatory endotypes in COPD
PJ Barnes - Allergy, 2019 - Wiley Online Library
Chronic obstructive pulmonary disease (COPD) is a major global health problem that is
poorly treated by current therapies as it has proved difficult to treat the underlying …
poorly treated by current therapies as it has proved difficult to treat the underlying …